This website uses cookies to provide you with the best experience. By using this site you agree to our use of cookies. Please read our cookie notice for more information.

Investor Releases

Date Title View
28 April, 2015 ICON Reports First Quarter 2015
23 April, 2015 ICON Launches Electronic Informed Consent
23 March, 2015 ICON and Carnegie Mellon University Collaborate to Evaluate Patient-centric Informed Consent Processes
09 March, 2015 ICON Launches Medical Device & Diagnostics Research Group
02 March, 2015 ICON Completes Acquisition of MediMedia Pharma Solutions
25 February, 2015 ICON Reports Fourth Quarter and Full Year 2014 Results and Issues 2015 Earnings Guidance
02 February, 2015 ICON to Acquire MediMedia Pharma Solutions
06 November, 2014 ICON Selected by the FDA to Develop New Patient-Reported Outcome Measure for Hospital-Acquired Bacterial Pneumonia Trials
22 October, 2014 ICON Reports Third Quarter 2014 and Increases Earnings Guidance
19 September, 2014 ICON Plc Announces Completion of $40 Million Share Buyback and a Further Share Buyback Program for up to $100 Million
01 August, 2014 ICON: Pfizer and Roche Join ADDPLAN DF Consortium
30 July, 2014 ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
30 July, 2014 ICON Reports Second Quarter 2014 and Increases Earnings Guidance
09 May, 2014 ICON to Webcast Analyst Day Meeting
08 May, 2014 ICON Completes Acquisition of Aptiv Solutions
30 April, 2014 ICON Announces Appointment of Dr. Hugh Brady to Board of Directors
30 April, 2014 ICON Reports First Quarter 2014
31 March, 2014 ICON to Acquire Aptiv Solutions
20 February, 2014 ICON Announces Appointment of Ms. Mary Pendergast to Board of Directors
20 February, 2014 ICON Reports Fourth Quarter 2013 Revenue of $345 million, up 15% year on year and EPS of 53c, up 56% year on year. Full Year 2013 Revenue was $1.34 billion, up 20% year on year, EPS was $1.77 up 77% year on year. Guidance issued for 2014.
Displaying 121 - 140 of 328

Search Investor